Status:
COMPLETED
Hemodialysis Vitamin D Pilot
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Collaborating Sponsors:
The Physicians' Services Incorporated Foundation
Conditions:
Vitamin D Deficiency
Renal Failure Chronic Requiring Hemodialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Vitamin D is a prohormone obtained through diet, supplementation, or sun exposure. Once absorbed, this nutritional vitamin D undergoes a two-step reaction in the liver and in the kidney to become the ...
Eligibility Criteria
Inclusion
- Participant is ≥ 18 years
- Participant is on hemodialysis ≥ 3 months
Exclusion
- Serum calcium \>2.75 mmol/L
- On concurrent vitamin D treatment ≥ 800 IU/day. Includes ergocalciferol, cholecalciferol, calcedidiol, over-the-counter vitamin D. Does not include one-alpha calcidol (One Alfa®) or 1, 25 di-hydroxy-D3 (Rocaltrol® or Calcijex®)
- Known hypersensitivity or allergy to Vitamin D
- End stage liver disease
- Severe untreated malabsorption or resection of large segment of small bowel
- Lack of informed consent or inability to consent
- Currently enrolled in a RCT
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01214928
Start Date
January 1 2011
End Date
June 1 2011
Last Update
July 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6